3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Neoplasms
3
Non-Muscle Invasive Bladder Neoplasms
2
Lymphoma, B-Cell
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Leukemia, Myeloid, Acute
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
Temozolomide
7
Vincristine
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Cyclophosphamide
4
cabozantinib
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
ALT-803
×
90 days
×
Clear all
No trials found.